Current Opinion in Nephrology and Hypertension was launched in 1992. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of nephrology and hypertension are divided into 12 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue.
David A. Bushinsky
Dr David A. Bushinsky received his medical degree from Tufts University School of Medicine in Boston, USA, and completed an internship and residency at the Tufts New England Medical Center Hospital. He also completed a fellowship in clinical nephrology and a research fellowship in nephrology at Tufts New England Medical Center.
Dr Bushinsky is the John J. Kuiper Distinguished Professor of Medicine and of Pharmacology and Physiology at the University of Rochester School of Medicine, USA. He is the Chief of the Nephrology Division at the University of Rochester Medical Center and Associate Chair for Academic Affairs in the Department of Medicine.
Dr Bushinsky is a member of a number of organizations including the Association of American Physicians and the American Society for Clinical Investigation.
He has published several hundred peer-reviewed articles, invited reviews, chapters, and editorials focusing on disorders of divalent ion metabolism. Dr Bushinsky developed a strain of rats that exhibit genetic hypercalciuria, the most common metabolic abnormality in humans with nephrolithiasis, and spontaneously formed kidney stones. The pathophysiology of the hypercalciuria closely parallels that of man and is thus a useful model to study stone formation in humans. He has also extensively studied the mechanism by which metabolic acids induce physicochemical bone dissolution and cell-mediated bone resorption. His research has been consistently funded by grants from the National Institutes of Health for three decades. Dr Bushinsky has lectured throughout the world on kidney stone formation, effects of acid on bone and other disorders of divalent ion metabolism.
Dr Tamara Isakova, MD, MMSc, is a graduate of the State University of New York Downstate College of Medicine, USA, and she completed internal medicine training at the Massachusetts General Hospital, Boston, USA. She also received nephrology training in the combined Massachusetts General Hospital and Brigham & Women's Hospital nephrology fellowship program
She is Associate Professor of Medicine in the Division of Nephrology and Hypertension at the Northwestern University Feinberg School of Medicine, Chicago, USA. She is also the Director of the Center for Translational Metabolism and Health within the Institute for Public Health and Medicine at Northwestern.
Dr Isakova conducts clinical research in the area of disordered mineral metabolism in chronic kidney disease. She has received research support from the American Kidney Fund, the American Heart Association, the American Society of Nephrology, and the National Institute of Health. Dr Isakova provides clinical care for patients with chronic kidney disease, bone and mineral metabolism disorders, and kidney stones.
Orson W. Moe
Dr Orson W. Moe received his medical degree from the University of Toronto, Canada and is currently Professor of Internal Medicine and Physiology at the University of Texas Southwestern Medical Center, Dallas, USA. He is the Director of the Charles and Jane Pak Center of Mineral Metabolism and Clinical Research and Chief of the Division of Nephrology. He is an active clinician and researcher holding the Charles and Jane Pak Distinguished Chair in Mineral Metabolism Research and the Donald Seldin Professorship in Clinical Investigation.
Orson Moe conducts both basic science and patient-oriented research on renal physiology and metabolism, as well as epithelial biology. His research strives to cross from the level of the whole patient, to animal and cell culture models, and down to single molecules. He is active in teaching at the undergraduate and post-graduate level nationally and internationally.
In addition to editing Current Opinion in Nephrology and Hypertension, Moe also edits the textbook, The Kidney: Physiology and Pathophysiology by Seldin and Giebisch. Moe is currently a member of the American Society of Clinical Research, American Association of Physicians, American Society of Nephrology, International Society of Nephrology, and the American Physiologic Society.
Dr Susan Quaggin graduated from the Faculty of Medicine at the University of Toronto, Canada, in 1988 and received her specialty degree in internal medicine in 1992. She completed her sub-specialty training in nephrology at University of Toronto in 1993, followed by a post-doctoral fellowship at Yale University, USA, where she studied the genetic basis of kidney development.
Dr Quaggin has served as an elected councillor of the American Society for Clinical Investigation (ASCI), is a member of the Executive Council of the ISN, and was elected to the American Association of Physicians (AAP) in 2013. In addition, Dr Quaggin sits on the editorial boards of several journals, is the Deputy Editor of the Journal of the American Society of Nephrology and has organized a number of international renal and vascular meetings.
In January 2013, Dr Quaggin joined Northwestern University Feinberg School of Medicine, USA, as the Charles Horace Mayo Professor of Medicine, where she serves as the Director of the Feinberg Cardiovascular Research Institute (FCVRI) and Chief of the Nephrology Division.
Dr Quaggin's research program focuses on genetic pathways required to establish and maintain the integrity of microvascular beds including the glomerular filtration barrier – a highly selective filter that separates the blood from the urinary space. To understand the pathways and interactions between perivascular cells and the endothelium, her research team has developed a number of genetic models that permit cell and time-specific manipulation of gene expression.